Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Piper Sandler

3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year

Check out these three defensive stocks that Wall Street analysts are upgrading their ratings on in the first few weeks of 2025.

MarketBeat

Why Nike Is on The Verge of a Massive Comeback Rally

The team at Piper Sandler just upgraded their rating on Nike from Neutral to Overweight, setting a fresh price target of $90.

MarketBeat

Stocks Recover on Strength in Health Insurers and Energy Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH25 ) are up +0.26%, and March E-mini Nasdaq futures...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

The Latest Analyst Ratings For CME Gr

In the preceding three months, 18 analysts have released ratings for CME Gr (NASDAQ:CME), presenting a wide array of perspectives from bullish to bearish.

Benzinga

What 16 Analyst Ratings Have To Say About Murphy Oil

During the last three months, 16 analysts shared their evaluations of Murphy Oil (NYSE:MUR), revealing diverse outlooks from bullish to bearish.

Benzinga

Decoding 23 Analyst Evaluations For HubSpot

Providing a diverse range of perspectives from bullish to bearish, 23 analysts have published ratings on HubSpot (NYSE:HUBS) in the last three months.

Benzinga

Critical Insights From Ulta Beauty Analyst Ratings: What You Need To Know

Ratings for Ulta Beauty (NASDAQ:ULTA) were provided by 28 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential

With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside.

Barchart

DocuSign Stock Jumps On Strong Q3, Analysts Await Proof Of Sustained Growth

DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.

Benzinga

Ulta Beauty Posts Upbeat Results, Joins Asana, Lululemon, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points on Friday.

Benzinga

Expert Outlook: Wells Fargo Through The Eyes Of 14 Analysts

Throughout the last three months, 14 analysts have evaluated Wells Fargo (NYSE:WFC), offering a diverse set of opinions from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Robinhood Markets Through 28 Analysts

Robinhood Markets (NASDAQ:HOOD) underwent analysis by 28 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Lululemon Athletica To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

What 9 Analyst Ratings Have To Say About Cracker Barrel Old

Throughout the last three months, 9 analysts have evaluated Cracker Barrel Old (NASDAQ:CBRL), offering a diverse set of opinions from bullish to bearish.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What Analysts Are Saying About Oracle Stock

Oracle (NYSE:ORCL) has been analyzed by 31 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Beyond The Numbers: 11 Analysts Discuss Adobe Stock

In the preceding three months, 11 analysts have released ratings for Adobe (NASDAQ:ADBE), presenting a wide array of perspectives from bullish to bearish.

Benzinga

Evaluating Amerant Bancorp: Insights From 5 Financial Analysts

Throughout the last three months, 5 analysts have evaluated Amerant Bancorp (NYSE:AMTB), offering a diverse set of opinions from bullish to bearish.

Benzinga

Marvell Technology Posts Solid Q3 Beat: Analysts Raise Forecasts, Expect 40%-50% Earnings Growth

Marvell Technology reported upbeat earnings amid exciting earnings season. Analysts raised their price targets, expecting strong growth.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

In-Depth Examination Of 20 Analyst Recommendations For Chipotle Mexican Grill

In the preceding three months, 20 analysts have released ratings for Chipotle Mexican Grill (NYSE:CMG), presenting a wide array of perspectives from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Workday Through 17 Analysts

Ratings for Workday (NASDAQ:WDAY) were provided by 17 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Unveiling 13 Analyst Insights On Clearwater Analytics Hldg

Across the recent three months, 13 analysts have shared their insights on Clearwater Analytics Hldg (NYSE:CWAN), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Where Accenture Stands With Analysts

17 analysts have shared their evaluations of Accenture (NYSE:ACN) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Robinhood Markets's Options: A Look at What the Big Money is Thinking

Financial giants have made a conspicuous bullish move on Robinhood Markets. Our analysis of options history for Robinhood Markets (NASDAQ:HOOD) revealed 8 unusual trades.

Benzinga

Bank of America To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Stryker

Ratings for Stryker (NYSE:SYK) were provided by 19 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.